Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor
- Author
- OSORIO, Juan C1 ; CHEEMA, Faisal H1 ; MARTENS, Timothy P1 ; MAHMUT, Naila2 ; KINNEAR, Caroline2 ; GONZALEZ, Ana M. D1 ; BONNEY, William1 ; HOMMA, Shunichi1 ; LIAO, James K3 ; MITAL, Seema4
[1] Columbia University, New York, NY, United States
[2] Hospital for Sick Children, Toronto, Ontario, Canada
[3] Brigham and Women's Hospital, Boston, Massachusetts, United States
[4] Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, NY, United States - Source
Canadian journal of physiology and pharmacology. = Journal canadien de physiologie et pharmacologie. 2008, Vol 86, Num 9, pp 633-642, 10 p ; ref : 1 p.1/2
- CODEN
- CJPPA3
- ISSN
- 0008-4212
- Scientific domain
- Pharmacology drugs; Physiology, morphology
- Publisher
- National Research Council of Canada, Ottawa, ON
- Publication country
- Canada
- Document type
- Article
- Language
- English
- Author keyword
- bradykinine cardiomyopathie hypertrophie oxyde nitrique protéine kinase activée par des agents mitogènes simvastatine échocardiographie
- Keyword (fr)
- Bradykinine Cardiomyopathie Echocardiographie Hypertrophie cardiaque Kinase Mammalia Mitogène Protéine Récepteur biologique Simvastatine Cardiopathie Dérivé de la statine Enzyme Hormone peptide Hydroxymethylglutaryl-CoA reductase Inhibiteur de l'HMG-CoA reductase Inhibiteur enzyme Neuropeptide Oxidoreductases Pathologie de l'appareil circulatoire Pathologie du myocarde Transferases Vertebrata
- Keyword (en)
- Bradykinin Cardiomyopathy Echocardiography Hypertrophied heart Kinase Mammalia Mitogen Protein Biological receptor Simvastatin Heart disease Statin derivative Enzyme Peptide hormone Hydroxymethylglutaryl-CoA reductase HMG-CoA reductase inhibitor Enzyme inhibitor Neuropeptide Oxidoreductases Cardiovascular disease Myocardial disease Transferases Vertebrata
- Keyword (es)
- Bradiquinína Cardiomiopatía Ecocardiografía Corazón hipertrofiado Kinase Mammalia Mitógeno Proteína Receptor biológico Simvastatina Cardiopatía Statina derivado Enzima Hormona péptido Hydroxymethylglutaryl-CoA reductase Inhibidor HMG-CoA reductase Inhibidor enzima Neuropéptido Oxidoreductases Aparato circulatorio patología Miocardio patología Transferases Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A16 Vertebrates: anatomy and physiology, studies on body, several organs or systems
- Discipline
- Vertebrates : anatomy and physiology, studies on body, several organs or systems
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20738845
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1139/Y08-068 
https://dx.doi.org/10.1139/Y08-068
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"633\";s:8:\"\u0000*\u0000epage\";s:3:\"642\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OSORIO\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Juan C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"CHEEMA, Faisal H\";i:1;s:18:\"MARTENS, Timothy P\";i:2;s:13:\"MAHMUT, Naila\";i:3;s:17:\"KINNEAR, Caroline\";i:4;s:18:\"GONZALEZ, Ana M. D\";i:5;s:15:\"BONNEY, William\";i:6;s:15:\"HOMMA, Shunichi\";i:7;s:13:\"LIAO, James K\";i:8;s:12:\"MITAL, Seema\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"633\";s:8:\"\u0000*\u0000epage\";s:3:\"642\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OSORIO\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Juan C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"CHEEMA, Faisal H\";i:1;s:18:\"MARTENS, Timothy P\";i:2;s:13:\"MAHMUT, Naila\";i:3;s:17:\"KINNEAR, Caroline\";i:4;s:18:\"GONZALEZ, Ana M. D\";i:5;s:15:\"BONNEY, William\";i:6;s:15:\"HOMMA, Shunichi\";i:7;s:13:\"LIAO, James K\";i:8;s:12:\"MITAL, Seema\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"633\";s:8:\"\u0000*\u0000epage\";s:3:\"642\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OSORIO\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Juan C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"CHEEMA, Faisal H\";i:1;s:18:\"MARTENS, Timothy P\";i:2;s:13:\"MAHMUT, Naila\";i:3;s:17:\"KINNEAR, Caroline\";i:4;s:18:\"GONZALEZ, Ana M. D\";i:5;s:15:\"BONNEY, William\";i:6;s:15:\"HOMMA, Shunichi\";i:7;s:13:\"LIAO, James K\";i:8;s:12:\"MITAL, Seema\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"633\";s:8:\"\u0000*\u0000epage\";s:3:\"642\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OSORIO\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Juan C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"CHEEMA, Faisal H\";i:1;s:18:\"MARTENS, Timothy P\";i:2;s:13:\"MAHMUT, Naila\";i:3;s:17:\"KINNEAR, Caroline\";i:4;s:18:\"GONZALEZ, Ana M. D\";i:5;s:15:\"BONNEY, William\";i:6;s:15:\"HOMMA, Shunichi\";i:7;s:13:\"LIAO, James K\";i:8;s:12:\"MITAL, Seema\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:15:\"10.1139\/Y08-068\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Canadian journal of physiology and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Can. j. physiol. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"633\";s:8:\"\u0000*\u0000epage\";s:3:\"642\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-4212\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OSORIO\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Juan C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"CHEEMA, Faisal H\";i:1;s:18:\"MARTENS, Timothy P\";i:2;s:13:\"MAHMUT, Naila\";i:3;s:17:\"KINNEAR, Caroline\";i:4;s:18:\"GONZALEZ, Ana M. D\";i:5;s:15:\"BONNEY, William\";i:6;s:15:\"HOMMA, Shunichi\";i:7;s:13:\"LIAO, James K\";i:8;s:12:\"MITAL, Seema\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CJPPA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:35:\"National Research Council of Canada\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
